Medicare Enrolled

Dr. Joseph Shanahan, MD

Rheumatology · Durham, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
2222 E NC HIGHWAY 54 STE 200, Durham, NC 27713
9194052040
In practice since 2006 (19 years)
NPI: 1043394901 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shanahan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shanahan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shanahan

Dr. Joseph Shanahan is a rheumatology specialist in Durham, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shanahan performed 223,755 Medicare services across 1,436 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shanahan received a total of $618,803 from 33 pharmaceutical and/or device companies across 1015 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shanahan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 4% volume in NC $618,803 industry payments

Medicare Practice Summary

Medicare Utilization ↗
223,755
Medicare services
Top 4% in NC for rheumatology
1,436
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~11,777 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tocilizumab injection (Actemra) 150,080 $5 $18
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
44,300 $11 $38
Romosozumab injection (Evenity) for osteoporosis 9,870 $8 $17
Denosumab injection (Prolia/Xgeva) 9,180 $18 $40
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
7,000 $33 $72
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
738 $91 $400
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
730 $89 $241
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
439 $51 $165
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
310 $10 $100
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
250 $126 $321
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
168 $20 $100
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
163 $0 $5
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
142 $11 $40
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
97 $61 $162
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
86 $47 $400
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
78 $4 $5
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
39 $1 $4
New patient office visit, complex (60-74 min) 31 $155 $392
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
22 $122 $319
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
18 $48 $144
Injection, methylprednisolone acetate, 40 mg 14 $6 $15
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
23.4% high complexity
76.0% medium
0.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$618,803
Total received (2018-2024)
Avg $88,400/year across 7 years
Top 2% in NC for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
1,015
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$597,089 (96.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$17,479 (2.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,235 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$15,796
2023
$48,628
2022
$69,198
2021
$23,156
2020
$67,335
2019
$164,061
2018
$230,628

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$13,345
Janssen Biotech, Inc.
$1,386
Novartis Pharmaceuticals Corporation
$253
ABBVIE INC.
$216
Amgen Inc.
$170
AstraZeneca Pharmaceuticals LP
$95
GENZYME CORPORATION
$82
UCB, Inc.
$69
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
Radius Health, Inc.
$42
Arcutis Biotherapeutics, Inc.
$16
Regeneron Healthcare Solutions, Inc.
$16
Aurinia Pharma U.S., Inc.
$15
Kiniksa Pharmaceuticals International, plc
$15
E.R. Squibb & Sons, L.L.C.
$14
Fresenius Kabi USA, LLC
$13
Top 3 companies account for 94.9% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$180,325
Lilly USA, LLC
$114,217
Novartis Pharmaceuticals Corporation
$96,608
GlaxoSmithKline, LLC.
$79,486
Regeneron Healthcare Solutions, Inc.
$38,278
Amgen Inc.
$29,999
Horizon Pharma plc
$22,183
ABBVIE INC.
$14,277
AbbVie, Inc.
$12,852
AbbVie Inc.
$12,058
Horizon Therapeutics plc
$7,272
UCB, Inc.
$4,745
Janssen Biotech, Inc.
$3,108
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,720
AstraZeneca Pharmaceuticals LP
$321
PFIZER INC.
$311
GENZYME CORPORATION
$262
Janssen Scientific Affairs, LLC
$203
Radius Health, Inc.
$154
E.R. Squibb & Sons, L.L.C.
$106
Genentech USA, Inc.
$66
Aurinia Pharma U.S., Inc.
$46
Cardinal Health 108, LLC
$32
MEDAC PHARMA, INC.
$24
Merck Sharp & Dohme Corporation
$23
Covidien LP
$22
Organon LLC
$19
Sonex Health, Inc.
$19
Arcutis Biotherapeutics, Inc.
$16
Kiniksa Pharmaceuticals International, plc
$15
Alexion Pharmaceuticals, Inc.
$13
Fresenius Kabi USA, LLC
$13
Hikma Pharmaceuticals USA
$11
Top 3 companies account for 63.2% of all-time payments
Associated products mentioned in payments ›
Arcalyst · BENLYSTA · Bimzelx · COSENTYX · Cimzia · DUPIXENT · EUCRISA · EVENITY · Enbrel · FORTEO · HUMIRA · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · LUPKYNIS · McGRATH · Mitigare · NEXPLANON · NUCALA · OFEV · OLUMIANT · ORENCIA · Otezla · PENNSAID · Prolia · RAYOS · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · ULTOMIRIS · ULTRAGUIDECTR · XELJANZ · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for rheumatology in NC.

Looking for a rheumatology specialist in Durham?
Compare rheumatologists in the Durham area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
39
Per 100K population
11.8
County median income
$79,501
Nearest hospital
UNC HOSPITALS
8.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shanahan is a mixed practice specialist, with above-average Medicare volume (top 4% in NC), with speaking/promotional industry engagement in the top 2% of NC peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Shanahan experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Shanahan performed 150,080 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shanahan receive payments from pharmaceutical companies?
Yes. Dr. Shanahan received a total of $618,803 from 33 companies across 1,015 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shanahan's costs compare to other rheumatologists in Durham?
Dr. Shanahan's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shanahan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →